Concepedia

Michael Messig

MM

31

Publications

2.6K

Citations

25

H-Index

1994

Active since

Affiliations

Pfizer (United States)(Current)

San Francisco General Hospital

Université Paris Cité

Heidelberg University

University of Copenhagen

Michael Messig is an author at Pfizer (United States) specializing in medicine, cardiovascular disease, and public health.

Top concepts

Publications per year

1994–2016

31

Publications

31

Lipid Treatment Assessment Project 2

David D. Waters, Carlos Brotons, Cheng-Wen Chiang et al. · Circulation · 2009 · 305 citations

Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis

Henrik Sillesen, Pierre Amarenco, Michael G. Hennerici et al. · Stroke · 2008 · 274 citations · Full text

Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy

Patrick Rossignol, Daniela Dobre, John J.V. McMurray et al. · Circulation Heart Failure · 2013 · 250 citations

Pharmacokinetics of Desipramine Coadministered With Sertraline or Fluoxetine

Sheldon Preskorn, Jeffrey Alderman, Menger Chung et al. · Journal of Clinical Psychopharmacology · 1994 · 190 citations

, , +10

Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy

David D. Waters, Jennifer E. Ho, S. Matthijs Boekholdt et al. · Journal of the American College of Cardiology · 2012 · 177 citations

, , +3

Rows per page

1–5 of 31